FDA Inspection
Nanophase Technologies CorporationNanophase Technologies Corporation – FDA Inspection, Apr 13, 2023
Record Details
This FDA Inspection record concerns Nanophase Technologies Corporation, with an inspection on April 13, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 22d2e70e-237e-4e93-9811-df1e87ad4563
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1205286
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Nanophase Technologies Corporation
6| Date | Classification | Office | Project area |
|---|---|---|---|
| January 9, 2026 | Not classified | Chicago District Office | |
| June 7, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 29, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 15, 2014 | NAI | Center for Food Safety and Applied Nutrition | Colors and Cosmetics Technology |
| November 17, 2011 | NAI | Center for Food Safety and Applied Nutrition | Food and Color Additives Petition Review |
Other documents for Nanophase Technologies Corporation
- FDA Inspection 1298600 - 2026-01-09
- FDA Inspection 1096141 - 2019-06-07
- FDA Inspection 1077501 - 2018-11-29
- FDA Inspection 896947 - 2014-09-15
- FDA Inspection 753672 - 2011-11-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.